- Raised $800k funding round, Apr 2018
About
Q2Pharma specializes in developing small-molecule drugs to be used in conjunction with commonly used antibiotics or as standalone medications against multi-drug-resistant (MDR) bacteria. The company's lead compound, F19, has shown promise in combating deadly MDR bacterial infections. Whereas antibiotics kill the bacteria, antivirulent F19 inhibits bacterial toxin release, allowing the immune system to do its job more effectively, resolving the infection. F19 has been shown to potentiate antibiotic efficacy, even for antibiotics to which the pathogen is otherwise resistant. Recent experiments have demonstrated F19's potent effects on several of the most common and deadly MDR bacteria. Q2Pharma's platform technology is exclusively licensed from Case Western Reserve University in the United States, where Q2Pharma CSO and cofounder Professor Menachem Shoham is an associate professor.
Funding history · 1 round · $800K total
Q&A
- What is Q2Pharma's primary focus?
- Q2Pharma specializes in developing small-molecule drugs to prevent multidrug-resistant bacterial infections, either in conjunction with antibiotics or as standalone medications.
- What is the status of Q2Pharma?
- Q2Pharma is currently inactive, having ceased operations in February 2024.
- When was Q2Pharma founded?
- Q2Pharma was founded in November 2015.
- How much funding has Q2Pharma raised in total?
- Q2Pharma has raised a total of $800,000.
- When was Q2Pharma's last funding round and who were the investors?
- Q2Pharma's last funding round was in April 2018, with investments from Opifer and bpd Partners a. s.
- Who are the co-founders of Q2Pharma?
- The co-founders of Q2Pharma are Jacob BenArie (CEO), Menachem Shoham (CSO), and Yaron Shoham, MD (Chief Medical Officer). Yair Alegranti was also a co-founder but is no longer with the company.
- What is Q2Pharma's lead compound?
- Q2Pharma's lead compound is F19, which inhibits bacterial toxin release to help the immune system combat deadly multidrug-resistant bacterial infections.
Team · 4
Sectors & technology
Highlights
Tags
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| linkedin.com/company/33257948 | |
| facebook.com/Q2Pharma | |
| YouTube | youtube.com/channel/UCP193M_xNO7W_TQVTL4B54Q |
Identifiers & details
| Founded | 2015-11 |
|---|---|
| Employees (exact) | 2 |
| Status reason | Non Active, Feb 2024 ceased to operate |